2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Leiomyoma
4
Papillomavirus Infections
3
Inflammation
2
Frailty
2
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Squamous Intraepithelial Lesions
1
Small Cell Lung Carcinoma
1
Radiodermatitis
1
Prostatic Neoplasms
1
Papilloma
1
Low-Grade Intraepithelial Neoplasia of Cervix
1
Liver Neoplasms
1
Liver Cirrhosis
1
Fibrosis
1
Esophageal Neoplasms
1
Deglutition Disorders
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Atypical Squamous Cells of the Cervix
1
Interventions
Exercise
5
Vitamin D
3
Resistance Training
3
Omeprazole
3
Etanercept
3
Dexmedetomidine
3
Ascorbic Acid
3
salicylsalicylic acid
2
palbociclib
2
epigallocatechin gallate
2
XENP 1595
2
Tea
2
Tablets
2
Surgical Procedures, Operative
2
Sufentanil
2
Spironolactone
2
Probiotics
2
Pioglitazone
2
Oxycodone
2
Nutrition Assessment
2
Morphine
2
Metformin
2
Ketorolac
2
Infliximab
2
Ibuprofen
2
Fish Oils
2
Endurance Training
2
Colchicine
2
Blood Specimen Collection
2
Aspirin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Inflammation
×
epigallocatechin gallate
×
Clear all
NCT04553666
2026-05-07
ReFOCUS1
University of Rochester
Phase 2
Completed
24 enrolled
17 charts
NCT06068543
2026-03-06
ReFOCUS2
University of Rochester
Phase 2
Recruiting
118 enrolled